'Shredding' cancer cells: Study of CRISPR-Cas3 brings us closer
January 19, 2024
January 19, 2024
ITHACA, New York, Jan. 19 -- Cornell University issued the following news:
Cornell researchers have taken an important step toward harnessing CRISPR gene editing in "targeted, safe and potent" cancer treatment, according to Ailong Ke, professor of chemistry and chemical biology in the College of Arts and Sciences.
The enzyme CRISPR-Cas3, one of many different CRISPR systems found naturally in the immune systems of bacteria, could ultimately be used to find uni . . .
Cornell researchers have taken an important step toward harnessing CRISPR gene editing in "targeted, safe and potent" cancer treatment, according to Ailong Ke, professor of chemistry and chemical biology in the College of Arts and Sciences.
The enzyme CRISPR-Cas3, one of many different CRISPR systems found naturally in the immune systems of bacteria, could ultimately be used to find uni . . .